Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial

INTRODUCTION: Despite optimal treatment, patients with chronic coronary artery disease (CAD) and diabetes mellitus (DM) are at high risk of cardiovascular events, emphasizing the need for new treatment options. The Low-Dose Colchicine 2 (LoDoCo2) trial demonstrated that colchicine reduces cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadnia, Niekbachsh, Los, Jan, Opstal, Tjerk S. J., Fiolet, Aernoud T. L., Eikelboom, John W., Mosterd, Arend, Nidorf, Stefan M., Budgeon, Charley A., Tijssen, Jan G. P., Thompson, Peter L., Tack, Cees J., Simsek, Suat, Bax, Willem A., Cornel, Jan H., El Messaoudi, Saloua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587438/
https://www.ncbi.nlm.nih.gov/pubmed/37868776
http://dx.doi.org/10.3389/fcvm.2023.1244529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587438/
https://www.ncbi.nlm.nih.gov/pubmed/37868776
http://dx.doi.org/10.3389/fcvm.2023.1244529

Ejemplares similares